University of New Mexico
Hudson received a BS in zoology and a BS in biology from the University of Washington in 1980 and her PhD in pharmacology and toxicology from Harvard University in 1985. She completed post-doctoral training in molecular endocrinology at the University of California, San Diego, and joined the UNM faculty in 1997.
Hudson has two major areas of research – mechanisms by which environmental metals disrupt protein function with an emphasis on inhibition of DNA repair, and investigating novel therapeutics for ovarian cancer and understanding molecular drivers of cancer metastasis. Her expertise is in skin and ovarian cancers and cellular mechanisms that lead to cancer development and progression. Hudson’s laboratory conducts investigations through biochemical, cell biological, in vivo and human translational approaches. She investigates novel therapeutics for ovarian cancer, which has led to a pilot clinical trial to investigate the pharmacokinetics and pharmacodynamics of a candidate therapeutic drug. Investigations on the mechanisms of environmental metal toxicity are moving into exposed human populations in the Southwest.